0001193125-17-134579.txt : 20170524 0001193125-17-134579.hdr.sgml : 20170524 20170424161055 ACCESSION NUMBER: 0001193125-17-134579 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20170424 FILER: COMPANY DATA: COMPANY CONFORMED NAME: DYNAVAX TECHNOLOGIES CORP CENTRAL INDEX KEY: 0001029142 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 330728374 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: 2929 SEVENTH STREET STREET 2: SUITE 100 CITY: BERKELEY STATE: CA ZIP: 94710 BUSINESS PHONE: 5108485100 MAIL ADDRESS: STREET 1: 2929 SEVENTH STREET STREET 2: SUITE 100 CITY: BERKELEY STATE: CA ZIP: 94710 CORRESP 1 filename1.htm CORRESP

DYNAVAX TECHNOLOGIES CORPORATION

2929 Seventh Street, Suite 100

Berkeley, CA 94710-2753

April 24, 2017

VIA EDGAR

Division of Corporation Finance

U.S. Securities and Exchange Commission

100 F Street, N.E.

Washington, D.C. 20549

Attn: Christine Westbrook

 

RE:   

Dynavax Technologies Corporation

Registration Statement on Form S-3

File No. 333-207966

   

Ladies and Gentlemen:

Pursuant to Rule 461 under the Securities Act of 1933, as amended, the undersigned registrant hereby requests that the Securities and Exchange Commission (the “Commission”) take appropriate action to cause the above-referenced Registration Statement on Form S-3 to become effective at 4:00 p.m. Eastern Time on April 26, 2017, or as soon thereafter as is practicable.

Thank you for your assistance. If you should have any questions, please contact Glen Sato or Marina Remennik of Cooley LLP, counsel to the Registrant, at (650) 843-5502 or (650) 843-5124.

 

DYNAVAX TECHNOLOGIES CORPORATION
By:   /s/ MICHAEL S. OSTRACH
  Michael S. Ostrach
  Senior Vice President and Chief Financial Officer